Live Quote · NYSEANVSHealthcare· Biotechnology

Annovis Bio, Inc.

$0.71▼ 4.96%($-0.04)
MKT CAP $30.36MNEXT EARNINGS Mar 15, 2027
50%
Bullish
TickerSpark Score
57/100
▌ Mixed
90
Valuation
40
Profitability
60
Growth
64
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANVS research report →

Analyst Price Target
$25.67+3508.9% vs. today

Range $21 – $30

Analyst RatingBuy
7 Buy2 Hold0 Sell

Price Chart

-81.67% · this period
$5.10$2.88$0.67Nov 20May 26Nov 20
52-Week Range2% of range
Low
$0.62
Current
$0.71
High
$5.50